Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Iron chelators and iron toxicity.

Gary M Brittenham1

  • 1Departments of Pediatrics and Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. gmb31@columbia.edu

Alcohol (Fayetteville, N.Y.)
|September 6, 2003
PubMed
Summary

Iron chelation shows promise for treating alcoholic liver disease by removing excess iron that worsens alcohol

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physiologically based serum hepcidin and ferritin thresholds identify similar onsets of iron-deficient erythropoiesis in adult blood donors.

British journal of haematology·2026
Same author

MRI Quantification of Liver Fibrosis Using Diamagnetic Susceptibility: An Ex Vivo Validation Study.

Tomography (Ann Arbor, Mich.)·2026
Same author

Effects of iron repletion on brain iron content, myelination, neural network activation, and cognition.

JCI insight·2025
Same author

Physiologically based serum ferritin thresholds for iron deficiency among women and children from Africa, Asia, Europe, and central America: a multinational comparative study.

The Lancet. Global health·2025
Same author

Galacto-oligosaccharides alone and combined with lactoferrin impact the Kenyan infant gut microbiota and epithelial barrier integrity during iron supplementation <i>in vitro</i>.

Microbiome research reports·2025
Same author

Physiologically based trimester-specific serum ferritin thresholds for iron deficiency in US pregnant women.

Blood advances·2024

Area of Science:

  • Hepatology
  • Pharmacology
  • Toxicology

Background:

  • Chronic alcohol and iron excess individually injure organs.
  • Combined, alcohol and iron exacerbate liver damage and fibrosis.
  • Iron's role in alcoholic liver disease pathogenesis is significant.

Purpose of the Study:

  • To explore iron chelation as a therapeutic strategy for alcoholic liver disease.
  • To review existing and novel iron chelating agents for potential clinical use.

Main Methods:

  • Review of the role of iron in alcoholic liver disease.
  • Discussion of deferoxamine B mesylate as a current iron chelator.
  • Introduction of novel iron chelating agents: HBED, 4'-OH-dadmDFT, ICL670A, and deferiprone.

Main Results:

  • Iron and alcohol synergistically promote hepatic fibrosis.
  • Existing iron chelator deferoxamine B mesylate is safe and effective for iron overload.
  • Several new iron chelators are in or near clinical trials.

Conclusions:

  • Iron chelation offers a potential new treatment for alcoholic liver disease.
  • Novel chelators may mitigate liver damage by neutralizing reactive iron species.
  • Targeting iron could be a key strategy in managing alcoholic liver injury.

Related Experiment Videos